Sabatolimab (MBG453) 10mg

Sabatolimab (MBG453) 10mg

Brand: RCpeptides
5500.00 EUR In stock Buy at Merchant

Sabatolimab (MBG453) is a humanized IgG4 monoclonal antibody used in the treatment of myeloid cancers, targeting TIM-3, and is part of the STIMULUS program.

  • The description claims that Sabatolimab is evaluated in the STIMULUS program (MDS/AML/CMML).
  • The description claims that Sabatolimab targets TIM-3, which is involved in T-cell and innate immune suppression/exhaustion-like states and contributes to myeloid malignancies.
Variants (1)
  • Default Title — 5500.00 EUR — In stock

How AI sees this product

The more complete this product's details, the more confidently AI assistants can understand and recommend it.

66%
4 details missing that AI looks for Claim to see how to fix it
Data sourced from rcpeptides.com. Last updated: This description was written with AI from the merchant's product information, so some details may vary.
Claim rcpeptides.com to control what AI sees, no website changes

Takes ~2 minutes. No changes to your website.